|
|
 |
 |
|
|
|
|
US News in Brief, July 30, 2010
|
30-Jul-2010
|
FDA clears Daiichi hypertension drug
Merck Serono MS pill wins priority review
Astellas and Regeneron extend deal
Counterfeit medicines summit
FDA approves drug for drooling
Read more...
|
|
First generic Lovenox approved
|
29-Jul-2010
|
In a controversial move, the US Food and Drug Administration has approved for marketing the first generic version of sanofi-aventis’ blockbuster blood-thinner Lovenox (enoxaparin sodium injection), which is indicated for a number of uses, including prevention of deep vein thrombosis
Read more...
|
|
FDA advisors support GSK's Avandia
|
15-Jul-2010
|
Members of two advisory committees to the US Food and Drug Administration voted on Wednesday to recommend that the Federal agency allow GlaxoSmithKline’s (GSK) blockbuster diabetes drug Avandia to stay on the market in spite of safety concerns
Read more...
|
|
Merck closing 16 facilities
|
12-Jul-2010
|
Merck is continuing to consolidate its operations following its merger with Schering-Plough, announcing on Thursday that it will close eight R&D facilities and eight manufacturing plants
Read more...
|
|
Celgene to buy biotech company
|
01-Jul-2010
|
Celgene Corporation has signed an agreement to buy Abraxis BioScience, a biotech firm focused on drug-delivery technology, for approximately $2.9 billion in upfront payments, in addition to potential milestone payments and royalties due to shareholders
Read more...
|
|
US News in Brief, July 1, 2010
|
01-Jul-2010
|
Effexor XR generic approved
Bill would expand pharmacists’ role
PhRMA names comparative effectiveness nominees
Biogen Idec appoints new CEO
Forest diabetes drug study fails
Lilly forms hypoglycemia drug pact
PhRMA objects to House bill
Read more...
|
|
FDA faulted on foreign trials oversight
|
24-Jun-2010
|
A new report from the Office of the Inspector General at the US Department of Health and Human Services has found that the US Food and Drug Administration needs to step up its oversight of foreign clinical trials conducted by drugmakers in support of their US marketing applications
Read more...
|
|
US News in Brief, June 24, 2010
|
24-Jun-2010
|
Ortho-McNeil in diabetes pact
Novo Nordisk restarts obesity program
Lilly partners with Wal-Mart
Pfizer withdraws cancer drug
Pharma is target of news hoax
Pfizer halts osteoarthritis trial
Read more...
|
|
|
Page  1 2 3 
|
 |
|
|
|
|
